Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that principal conditions including the Company’s liquidity condition and historical operating losses raise substantial doubt about the Company’s ability to continue as a going concern for a period of time of at least one year after the date that the accompanying consolidated financial statements are issued. ... There is no assurance that the Company’s plans to alleviate such concerns will be successful or successful within one year after the date the condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
One customer — 46% of revenue (the three months ended June 30, 2026)
“The Company has one customer whose revenue accounted for approximately 46% and 43% of the Company's total revenue for the three months ended June 30, 2026, and six months ended June 30, 2026, respectively.”
One customer — 43% of revenue (the six months ended June 30, 2026)
“The Company has one customer whose revenue accounted for approximately 46% and 43% of the Company's total revenue for the three months ended June 30, 2026, and six months ended June 30, 2026, respectively.”
2 customers — 23% of receivables (June 30, 2026)
“In aggregate, the Company had two customers whose accounts receivable represented 23% of the Company's total accounts receivable as of June 30, 2026.”
3 customers — 43% of receivables (December 31, 2025)
“In the aggregate, the Company had three customers whose accounts receivable represented 43% of the Company's total accounts receivable as of December 31, 2025.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
VSee Health, Inc. registered up to 3,540,000 common shares for resale by ClearThink Capital Partners, LLC, comprising 40,000 commitment-fee shares and 3,500,000 shares issuable under a $5.0 million purchase commitment dated September 2, 2026.
VSee Health, Inc. issued an additional unsecured convertible promissory note on September 24, 2026, with $180,550 principal, a $23,550 discount and one-time 12% interest. It is due July 30, 2027; conversion after default is subject to a 4.99% ownership cap.
VSee Health, Inc. effected a 1-for-80 reverse stock split of its Common Stock at 5:00 p.m., eastern time on September 23, 2026; split-adjusted trading begins at the market open on Thursday, September 24, 2026.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VSEE
this stock
Vsee Health, Inc.
|
$1.59M | -91.2% | +40.3% | — | 0.6% |
|
VEEV
Veeva Systems Inc
|
$49.09B | +35.8% | +28.1% | 49.6 | 2.6% |
|
TEM
Tempus AI, Inc.
|
$14.53B | +31.8% | +83.4% | — | 13.9% |
|
PMDIY
Pro Medicus Ltd.
|
$14.38B | -17.1% | — | — | 0.1% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.90B | +86.5% | +28.2% | 38.0 | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
VSee Health, Inc. registered up to 3,540,000 common shares for resale by ClearThink Capital Partners, LLC, comprising 40,000 commitment-fee shares and 3,500,000 shares issuable under a $5.0 million purchase commitment dated September 2, 2026.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VSEE | -54.2% | -68.6% | -89.8% | -58.2% | -91.2% |
| SPY | +3.6% | +2.2% | +12.8% | +2.9% | +12.7% |
| vs SPY | -57.8% | -70.8% | -102.6% | -61.1% | -103.9% |
